It’s a hat trick for Pegasus!
October 16, 2014 |
Pegasus scoops the much-coveted “Consultancy of the Year” prize at the PR Week Awards 2014
Pegasus, the UK’s leading independent health communications consultancy, picked up the prestigious “Consultancy of the Year” award at Tuesday night’s PR Week Awards 2014.
Pegasus was also successful in the “Mid-Sized Consultancy of the Year” category (for agencies with UK turnover between £2m and £10m), and completed its hat trick winning the “Healthcare: Ethical & OTC Consumer” award for its work on Bayer Animal Health’s Slimewatch campaign.
This win marks Pegasus’s evolution from a traditional PR agency to an integrated comms consultancy that offers a multiservice approach to its clients, including social, digital and creative services.
With campaigns that span local, national and international markets and the creation of a network of global independent affiliate agencies across five continents, it’s no surprise that Pegasus represents a raft of well known companies and brands such as GSK, Pfizer, Bayer, Holland & Barrett, Bio-Oil and Danone to name a few. These awards are further confirmation that the consultancy continues to go from strength to strength, creating outstanding integrated campaigns that really bring healthcare into the mainstream. This is the third consultancy award win for the agency this year.
It has seen five years of double-digit growth, with last year’s fee income of £6m helping it climb ten places in this year’s PR Week Top 150 PR Consultancies report to number 38.
Fishburn CEO, Ali Gee said: “Pegasus has everything; it’s clear who they are, what they do and what makes them special.
Their purpose – inspiring health decisions – defines everything they do, and we were particularly impressed by the way they have reached beyond the healthcare sector.” 
Lisa Bradley, managing director at Pegasus, commented: “We’re absolutely delighted to have won, not just one, but three awards at the PR Week Awards this year. I’ve always looked at the winners of the “Consultancy of the Year” award with great admiration and am so proud that we are now that agency.”
ENDS
For more information please contact Maria Boiling or Amy Simmons at Pegasus on 01273 712000 or mboiling@thisispegasus.co.uk / asimmons@thisispegasus.co.uk
Notes to editors
Located in Brighton with a 75-strong team of communications experts, Pegasus specialises in helping the public and private sector communicate healthy messages through integrated communications programmes. Focusing on an overall mission to ‘Inspire Healthy Decisions’ and driven by a health first, sector second approach, Pegasus has a demonstrative track record of creating and implementing campaigns that inspire change.
The Pegasus approach to planning starts by investing time understanding the varied nature of decisions in every area of people’s day to day lives, from the general public through to the healthcare professionals that treat and the policy makers that shape the environment in which they work. The consultancy’s fully integrated approach blends unrivalled health contacts across the international, national, consumer, regional and specialist press, with in-house corporate, creative, social and digital services.
Pegasus’s clients currently include GSK, Pfizer, Boehringer Ingelheim, Bayer, Thornton & Ross, Holland & Barrett, Sanofi, Bio-Oil, Danone, Homedics, Novo Nordisk and Pierre Fabre. For more information please visit www.thisispegasus.co.uk.
This content was provided by Inizio
Company Details
Latest Content from Inizio
Infographic: Therapy Watch Acute Myeloid Leukemia market snapshot
This Acute Myeloid Leukemia infographic offers a snapshot of the real-world patient insights collected by our Therapy Watch study, based on data collected from a panel of 220 physicians across...
Navigating the future of AI: Insights from EphMRA’s one day meeting in London
Authored by: Ellie Forde and Mark Braund, Directors
Research conducted for Johnson and Johnson published in scientific journal
Findings from a study conducted by Dr. Chris Gaj, Vice President at Research Partnership, has been published in Clinical Genitourinary Cancer.
Connecting our Inizio Advisory capabilities to help a client address a threat to the brand, guide strategy and improve brand performance
The challenge Our client knew that prescribing of a key brand in a major market had slowed and needed to understand which patient segments were impacted so they could address...
Autoimmune conditions: Living With syndicated patient reports
The prevalence of autoimmune conditions is increasing, and despite significant advancements in treatments, individuals affected by these diseases may not be receiving the most effective management and care. In our...
How we elevated HCP market research engagement and insights using AI avatars for an immersive experience
Our client required an effective strategy for promoting discussions about self-paid vaccines with healthcare professionals (HCPs) during patient consultations. The conventional method of conducting market research would typically only deliver...
How we provided comprehensive real-world patient data for PAH using Therapy Watch, our syndicated market tracking solution
PAH is a specific type of pulmonary hypertension, which is a rare condition treated primarily in specialized centers. Our client needed to gain a comprehensive understanding of PAH patients, such...
The risk of replicating social bias in synthetic patient data – The need for human intelligence partnered with AI
Authored by Paul Reed and Anabelle Gall
Latest European developments and new talent at Research Partnership
Angela Duffy has been appointed as Managing Director for our European based ad hoc research teams. Angela has been an integral part of Research Partnership for 19 years, witnessing its...
New syndicated report – Living with Ulcerative Colitis 2024
Living with Ulcerative Colitis (UC) is a new syndicated patient report that presents valuable insights into the unmet needs and the burden experienced by patients living with UC. The report...